contraindication for tirzepatide Dos and Don'ts: Essential Safety Guidelines Tirzepatide (Mounjaro) In Sherman Oaks

Calculate your personalized protein target instantly

Understanding the mechanics, expectations, and support system ensures your success from day one

PlexusDx explains how to recognize when your injection has exceeded its shelf life and why fresh medication ensures optimal weight loss outcomes

Carmot Therapeutics has revealed preliminary data from the single ascending dose (SAD) portion of its ongoing Phase 1 clinical trial for CT-996, an oral small molecule GLP-1 receptor agonist (RA) currently being evaluated in a first-in-human clinical trial in participants with obesity or overweight.CT-996 is a once-daily oral, small molecule GLP-1 receptor agonist being developed for the treatment of obesity and type 2 diabetes (T2D)